Celyad SA ADR Stock
Your prediction
Celyad SA ADR Stock
Our community identified positive and negative aspects for Celyad SA ADR stock for the coming years. 0 users see the criterium "Worthwhile Investment for the next years" as a plus for the Celyad SA ADR stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Celyad SA ADR in the next few years
Pros
?
C******** o* t** e**********
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Celyad SA ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Celyad SA ADR | - | - | - | - | - | - | - |
| Cardio3 Biosciences S.A. | -0.860% | 3.125% | 20.313% | -37.903% | 71.111% | -53.144% | -93.135% |
| Intellia Therapeutics Inc | -3.430% | -1.907% | -37.517% | -9.171% | 18.627% | -75.948% | -92.254% |
| Chromadex Corp | 2.880% | 2.143% | 3.623% | -65.122% | -48.000% | 90.667% | -60.822% |